Start Date
March 31, 2002
Primary Completion Date
March 31, 2005
Study Completion Date
March 31, 2005
Olanzapine, risperidone
Stanford
Miami
Atlanta
Augusta
Chicago
Shreveport
Boston
Worcester
Minneapolis
St Louis
Las Vegas
Brooklyn
New York
Butner
Chapel Hill
Charlotte
Cincinnati
Cleveland
Kettering
Philadelphia
Conroe
Research Site, Dallas
San Antonio
Salt Lake City
Calgary
Halifax
Lead Sponsor
University of North Carolina
OTHER
AstraZeneca
INDUSTRY